Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine

MenACWY-CRM, a quadrivalent meningococcal conjugate vaccination, is licenced for use in individuals as young as 2 months old in the Republic of Korea. This single-arm, open-label, observational, ...

from crm - BingNews https://ift.tt/3z9gKK0
July 19, 2021 at 02:14PM